Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Libtayo Monotherapy Trial in Advanced Cervical Cancer Stopped Early for OS Positive Result

americanpharmaceuticalreviewMarch 22, 2021

Tag: Libtayo , Regeneron , Sanofi , IDMC , Cervical Cancer

PharmaSources Customer Service